Details van artikel 257 van 435 gevonden artikelen
P043 Significant reduction in abdominal symptoms assessed with the CFAbd-Score over 6 months of elexacaftor/tezacaftor/ivacaftor (ETI) - follow-up results from Irish and British cystic fibrosis patients (RECOVER study)
Titel:
P043 Significant reduction in abdominal symptoms assessed with the CFAbd-Score over 6 months of elexacaftor/tezacaftor/ivacaftor (ETI) - follow-up results from Irish and British cystic fibrosis patients (RECOVER study)
Auteur:
Mainz, J.G. Fleming, A. Elnazir, B. Williamson, M. McKone, E. Cox, D. Linnane, B. Zagoya, C. Davies, J. McNally, P.
Verschenen in:
Journal of cystic fibrosis
Paginering:
Jaargang 21 () nr. S1 pagina's S72-S73
Jaar:
2022
Inhoud:
Uitgever:
European Cystic Fibrosis Society. All rights reserved
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 257 van 435 gevonden artikelen